Riverhead Capital Management’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$277K Hold
1,735
0.01% 981
2019
Q2
$437K Hold
1,735
0.02% 779
2019
Q1
$415K Sell
1,735
-3,100
-64% -$743K 0.02% 793
2018
Q4
$1.11M Buy
4,835
+340
+8% +$83.8K 0.05% 417
2018
Q3
$1.27M Buy
4,495
+3,260
+264% +$955K 0.05% 426
2018
Q2
$363K Hold
1,235
0.01% 811
2018
Q1
$312K Hold
1,235
0.01% 862
2017
Q4
$267K Hold
1,235
0.01% 943
2017
Q3
$229K Buy
1,235
+236
+24% +$41.2K 0.01% 932
2017
Q2
$172K Buy
999
+499
+100% +$80.1K 0.01% 987
2017
Q1
$76K Hold
500
﹤0.01% 1102
2016
Q4
$74K Hold
500
﹤0.01% 1087
2016
Q3
$63K Sell
500
-55,138
-99% -$6.65M ﹤0.01% 1094
2016
Q2
$497K Buy
55,638
+52,348
+1,591% +$5.43M 0.02% 611
2016
Q1
$343K Sell
3,290
-110
-3% -$10.5K ﹤0.01% 1054
2015
Q4
$383K Buy
3,400
+2,400
+240% +$265K 0.01% 1027
2015
Q3
$110K Buy
+1,000
New +$107K ﹤0.01% 1042

Other funds holding ICUI

Riverhead Capital Management's ICUI Position: Q3 2019 in Review

Riverhead Capital Management held its ICU Medical (ICUI) position steady in Q3 2019 at 1,735 shares worth $277K. The position accounts for 0.01% of the portfolio, ranked #981.

Riverhead Capital Management first reported a position in ICUI in Q3 2015 and has held it in 17 quarters since. The position peaked at $1.27M in Q3 2018. 260 funds tracked by Wall St. Rank hold ICUI as of Q3 2019.

  • Riverhead Capital Management held 1,735 shares of ICU Medical worth $277K as of Q3 2019.
  • Riverhead Capital Management left its ICU Medical share count unchanged in Q3 2019.
  • ICU Medical made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #981 holding.
  • Riverhead Capital Management first reported a position in ICU Medical in Q3 2015 and has held it in 17 quarters since.
  • Riverhead Capital Management's ICU Medical position peaked at $1.27M in Q3 2018.
  • 260 funds tracked by Wall St. Rank held ICU Medical as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.